Chemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications
In view of many European countries and the USA leading to the second wave of COVID-19
pandemic, winter season, the evolution of new mutations in the spike protein, and no …
pandemic, winter season, the evolution of new mutations in the spike protein, and no …
Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies
Repurposing of existing drugs and drug candidates is an ideal approach to identify new
potential therapies for SARS-CoV-2 that can be tested without delay in human trials of …
potential therapies for SARS-CoV-2 that can be tested without delay in human trials of …
[HTML][HTML] Potential SARS-CoV-2 nonstructural proteins inhibitors: drugs repurposing with drug-target networks and deep learning
SK Azmoodeh, IF Tsigelny… - Frontiers in Bioscience …, 2022 - imrpress.com
Background: In the current COVID-19 pandemic, with an absence of approved drugs and
widely accessible vaccines, repurposing existing drugs is vital to quickly developing a …
widely accessible vaccines, repurposing existing drugs is vital to quickly developing a …